Bifurcation analysis of a tuberculosis progression model for drug target identification
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Bifurcation analysis of a tuberculosis progression model for drug target identification ; volume:13 ; number:1 ; day:16 ; month:10 ; year:2023 ; pages:1-15 ; date:12.2023
Scientific reports ; 13, Heft 1 (16.10.2023), 1-15, 12.2023
- Urheber
-
Flores-Garza, Eliezer
Hernández-Pando, Rogelio
García-Zárate, Ibrahim
Aguirre, Pablo
Domínguez-Hüttinger, Elisa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44569-7
- URN
-
urn:nbn:de:101:1-2024020512153230716802
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Flores-Garza, Eliezer
- Hernández-Pando, Rogelio
- García-Zárate, Ibrahim
- Aguirre, Pablo
- Domínguez-Hüttinger, Elisa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Publisher Correction: Bifurcation analysis of a tuberculosis progression model for drug target identification
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
Drug-drug relationship based on target information: application to drug target identification
The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis : biochemical and immunological characterization
Commentary: A targets framework: Dismantling the invisibility trap for children with drug-resistant tuberculosis
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression
The “funitel” technique for endoscopic target biopsy at a biliary bifurcation
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis
Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets
Publisher Correction: Bifurcation analysis of a tuberculosis progression model for drug target identification
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
Drug-drug relationship based on target information: application to drug target identification
The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis : biochemical and immunological characterization
Commentary: A targets framework: Dismantling the invisibility trap for children with drug-resistant tuberculosis
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression
The “funitel” technique for endoscopic target biopsy at a biliary bifurcation
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis
Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets
Publisher Correction: Bifurcation analysis of a tuberculosis progression model for drug target identification
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
Drug-drug relationship based on target information: application to drug target identification
The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis : biochemical and immunological characterization
Commentary: A targets framework: Dismantling the invisibility trap for children with drug-resistant tuberculosis
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression
The “funitel” technique for endoscopic target biopsy at a biliary bifurcation
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis